Specifying hazard rates stpower exponential [ h1 h2, options Specifying survival probabilities stpower exponential s1 s2, t(#) options Power determination Specifying hazard rates stpower exponential [ h1 h2, n(numlist) options Specifying survival probabilities stpower exponential s1 s2, t(#) n(numlist) options where h1 is the hazard rate in the control group; h2 is the hazard rate in the experimental group; s1 is the survival probability in the control group at reference (base) time t; and s2 is the survival probability in the experimental group at reference (base) time t. h1, h2 and s1, s2 may each be specified either as one number or as a list of values (see [U] 11.1.8 numlist) enclosed in parentheses. 1 2 stpower exponential — Sample siz...
SIGLETechnische Informationsbibliothek Hannover: RN 7349 (97) / FIZ - Fachinformationszzentrum Karls...
Group sequential design has been widely applied in clinical trials in the past few decades. The samp...
<div><p>Group sequential design has been widely applied in clinical trials in the past few decades. ...
Sample-size determination stpower cox [...] [ ,...] stpower logrank [...] [ ,...] stpower exponent...
Compute sample size power twoproportions p1 p2, power(numlist) options Compute power power twopropor...
Compute sample size power oneproportion p0 pa, power(numlist) options Compute power power oneproport...
Compute sample size power method..., power(numlist) power options... Compute power power method..., ...
When designing a cancer clinical trial, it is usual to assume an exponential distribution for a time...
Compute sample size power twomeans m1 m2, power(numlist) options Compute power power twomeans m1 m2,...
We propose a method for calculating power and sample size for studies involving interval-censored fa...
In many pharmaceutical studies, non-inferiority clinical trials are usually conducted because of the...
We present a menu-driven Stata program for the calculation of sample size or power for complex clini...
We present menu- and command-driven Stata programs for the calculation of sample size, number of eve...
Sizes and power of selected two-sample tests of the equality of survival distributions are compared ...
<p>* <i>λ</i><sub>i</sub> denotes the hazard function of <i>S</i><sub>i</sub>(<i>t</i>), a piecewise...
SIGLETechnische Informationsbibliothek Hannover: RN 7349 (97) / FIZ - Fachinformationszzentrum Karls...
Group sequential design has been widely applied in clinical trials in the past few decades. The samp...
<div><p>Group sequential design has been widely applied in clinical trials in the past few decades. ...
Sample-size determination stpower cox [...] [ ,...] stpower logrank [...] [ ,...] stpower exponent...
Compute sample size power twoproportions p1 p2, power(numlist) options Compute power power twopropor...
Compute sample size power oneproportion p0 pa, power(numlist) options Compute power power oneproport...
Compute sample size power method..., power(numlist) power options... Compute power power method..., ...
When designing a cancer clinical trial, it is usual to assume an exponential distribution for a time...
Compute sample size power twomeans m1 m2, power(numlist) options Compute power power twomeans m1 m2,...
We propose a method for calculating power and sample size for studies involving interval-censored fa...
In many pharmaceutical studies, non-inferiority clinical trials are usually conducted because of the...
We present a menu-driven Stata program for the calculation of sample size or power for complex clini...
We present menu- and command-driven Stata programs for the calculation of sample size, number of eve...
Sizes and power of selected two-sample tests of the equality of survival distributions are compared ...
<p>* <i>λ</i><sub>i</sub> denotes the hazard function of <i>S</i><sub>i</sub>(<i>t</i>), a piecewise...
SIGLETechnische Informationsbibliothek Hannover: RN 7349 (97) / FIZ - Fachinformationszzentrum Karls...
Group sequential design has been widely applied in clinical trials in the past few decades. The samp...
<div><p>Group sequential design has been widely applied in clinical trials in the past few decades. ...